Modular Medical submits MODD1 insulin pump to FDA for 510(k) clearance

Modular Medical, Inc.

Submitted MODD1 next-generation insulin pump to FDA for 510(k) clearance on Jan 19, 2024.
Expects initial FDA questions during quarter ending June 30, 2023 (as stated in press release).
Plans to file for UKCA mark to market MODD1 in the United Kingdom.
CEO Jeb Besser and Chairman Paul DiPerna highlighted simplified design to boost pump adoption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.